Contract Services
AtomVie Global Radiopharma builds industry-leading CDMO facility in Ontario.
Currently located on the McMaster University campus, AtomVie successfully operates a global leading Contract Development and Manufacturing Organi...
March 02, 2023 | News
Thermo Fisher Scientific’s Clinical Research Business Recognized by ISG for Digital Services Leadership
In its 2022 ISG Provider Lens™ Life Sciences Digital Services Global Report, ISG recognized Thermo Fisher’s clinical research business for...
February 27, 2023 | News
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...
February 27, 2023 | News
GenScript ProBio and RVAC Medicines Partner for COVID-19 Vaccine Plasmid DNA Manufacturing
GenScript ProBio will provide GMP plasmid manufacturing service for RVAC Medicines' program, RVM-V001. This partnership will enable to accelerate its clini...
February 23, 2023 | News
Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide ...
February 21, 2023 | News
EmVenio prioritizes inclusion in clinical research with new patient-centric model
In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diver...
February 18, 2023 | News
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck
In addition, Aqilion is eligible to receive potential development and commercialization milestones up to over EUR 950 million and tiered royaltie...
February 17, 2023 | News
Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
The investment has also increased the facility’s capabilities to support larger packaging campaigns through the addition of specialized secondary pac...
February 15, 2023 | News
Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301.
In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is prou...
February 15, 2023 | News
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...
February 10, 2023 | News
Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease
The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10 In the maintenance phase, filgotinib ...
February 09, 2023 | News
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center
The additional investment for the ‘R&PD Center’ was confirmed by the board of directors committee with a total of 261 million USD SK bio...
February 08, 2023 | News
Beyond Traditional Placebo Controls in Rare Disease Clinical Trials
The Collaborative Trajectory Analysis Project (cTAP), a global coalition in rare disease, has announced evidence to support patient-centric alternativ...
February 08, 2023 | News
Suvoda Introduces Extensible Software Platform Bringing Proven Tech Innovation to Clinical Trial Management
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...
February 07, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
